United States Polymerase chain reaction market 2025: Industry Developments, Future Growth, Share & Industry Insights | Abbott, QIAGEN, Bio-Rad Laboratories, Inc., Cepheid, Illumina, Inc., Takara Bio Inc

Polymerase chain reaction market size reached US$ 11.58 Billion in 2023 with a rise of US$ 12.33 Billion in 2024 and is expected to reach US$ 22.66 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033.

According to DataM Intelligence Comprehensive Report has released its latest report on the "Polymerase Chain Reaction Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/polymerase-chain-reaction-market?sg

Industry Developments:

✅ 08 July 2025: Bio‐Rad Laboratories, Inc. completed the acquisition of Stilla Technologies, a developer of next‐generation digital PCR (dPCR) systems.

✅ 07 July 2025: Bio‐Rad launched four new Droplet DigitalTM PCR platforms (QX ContinuumTM plus the acquired QX700TM series) expanding its dPCR instrument portfolio.

✅ 18 June 2025: QIAGEN N.V. and GENCURIX, Inc. announced a partnership via QIAGEN's QIAcuityDx Partnering Program to develop multiplex oncology assays for the QIAcuityDx digital PCR platform.

✅ 24 July 2025: Seegene Inc. unveiled CURECATM, the world's first fully unattended PCR automation system, and STAgoraTM, a real‐time big‐data analytics platform, at the ADLM 2025 conference.

✅ 17 September 2025: Co‐Diagnostics, Inc. signed a Memorandum of Understanding (MoU) with a Saudi partner to establish a joint venture for PCR manufacturing and distribution in the Middle East.

✅ 16 October 2025: Co‐Diagnostics announced development of a proprietary sample‐preparation instrument designed to simplify point‐of‐care PCR workflows (for their upcoming MTB test) enabling decentralized PCR testing.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/polymerase-chain-reaction-market?sg

Key Segments:

By-Product (Instruments, Reagents and Consumables, Software)

By Type (Real-time PCR Systems, Standard PCR Systems, Digital PCR Systems)

By Application (Medical Applications, Non-Medical Applications, and Others)

By End User (Hospitals and Clinics, Diagnostic Centers, Pharmaceutical and Biotechnology Industries, Academic and Research Organizations and Others)

Market Geographical Share

North America holds a leading share of the global PCR market. For example, reports estimate the region accounted for about 40 % of revenue in 2023. In earlier years, shares around 36-37 % have also been cited.

Europe comes next as a major region, supported by advanced healthcare systems and molecular diagnostics infrastructure.

The Asia‐Pacific region is the fastest‐growing region. Although its current share is smaller than North America's, rising healthcare investment and diagnostics uptake are driving strong compound annual growth rates in the region.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=polymerase-chain-reaction-market?sg

Key Market Drivers

✅ Rising burden of infectious and chronic diseases
The increasing incidence of infectious diseases (including viral outbreaks) and chronic conditions such as cancer and genetic disorders is fuelling demand for accurate molecular diagnostics and PCR lies at the heart of these diagnostics approaches.

✅ Technological innovation in PCR methodologies
Advances such as real‐time PCR, digital PCR, multiplexing, microfluidics and automation are improving sensitivity, throughput, and cost‐effectiveness. These innovations expand the application scope of PCR and encourage uptake.

✅ Growing adoption in clinical diagnostics and research
As healthcare systems increasingly integrate molecular diagnostics for early disease detection, treatment monitoring, and personalised medicine, PCR equipment, reagents and services become more central in hospitals, diagnostic labs, biotech R&D and academic institutions.

✅ Improving infrastructure and funding - especially in emerging regions
In regions such as Asia‐Pacific, government programmes, rising healthcare expenditure and biotech investment are enabling greater access to PCR-based diagnostics and research tools. This acts as a key driver for growth in those geographies.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/polymerase-chain-reaction-market?sg

Major Key Player: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott, QIAGEN, Bio-Rad Laboratories, Inc., Cepheid, Illumina, Inc., Takara Bio Inc., Standard BioTools, BD.

✅ Thermo Fisher Scientific, Inc.: A global leader in PCR technologies and life‐science tools, frequently cited among the top revenue‐generators in the PCR market.

✅ F. Hoffmann‐La Roche Ltd.: A major diagnostics and life‐science company with a substantial PCR‐market presence, especially via its molecular diagnostics business.

✅ Abbott: A significant player in molecular diagnostics and PCR‐based testing, contributing to the broader PCR market.

✅ QIAGEN N.V.: Specialised in molecular diagnostics and PCR reagents/consumables, aiming to outpace market growth and gain share.

✅ Bio‐Rad Laboratories, Inc.: A strong participant in PCR instrumentation and consumables, listed among the dominant firms in PCR markets.

✅ Cepheid: Known for PCR‐based diagnostics platforms (especially point‐of‐care), contributing to the PCR market niche.

✅ Illumina, Inc.: While primarily recognised for next‐generation sequencing, the company plays a role in PCR and related molecular‐testing markets.

✅ Takara Bio Inc.: A specialist in PCR reagents, qPCR/dPCR technologies and enzyme systems, representing the reagents segment of the PCR market.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.